To the Editor: Meloncelli and colleagues1 have provided clear evidence that a fasting venous plasma glucose (FVPG) assessment may be used to decrease the number of unnecessary oral glucose tolerance tests (OGTTs) for low risk women. This would be a very welcome step forward. However, it does [...]
To the Editor: Good clinical decisions should weigh benefits against harms. The recent JAMA Insights article on gestational diabetes mellitus (GDM) focused on the potential benefits of increased detection and treatment of GDM and subsequent promotion of cardiovascular health.1 Unmentioned were the potential detrimental effects of overdiagnosis [...]
We read the article by Nethery and colleagues with great interest, having noted a similar dramatic increase in the incidence of gestational diabetes in Australia, coincident with widespread adoption of the 1-step test using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. [...]
When Sophie was pregnant with her first baby, she had an oral glucose tolerance blood test. A few days later, the hospital phoned telling her she had gestational diabetes. Despite having only a slightly raised glucose (blood sugar) level, Sophie describes being diagnosed as affecting her pregnancy [...]
The definition of gestational diabetes mellitus (GDM) varies considerably depending on the region where a woman lives, and considerable controversy remains on the best approach to diagnosis. A 2021 trial showed no benefit for women or infants screened with the International Association of the Diabetes [...]
Sarah lives in London. She is pregnant with her first child. Her mother had gestational diabetes and Sarah is told this puts her into a higher risk category for the condition, thus she should have a test...